Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 2 Double-blinded, Placebo-controlled, Clinical Trial for Safety and Efficacy of Methylprednisolone Infiltration in Anserine Bursitis Treatment

NCT01205477 is registered in ClinicalTrials.gov with Universidad Autonoma de Nuevo Leon as lead sponsor.

NCT NCT01205477
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01205477 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 2 Double-blinded, Placebo-controlled, Clinical Trial for Safety and Efficacy of Methylprednisolone Infiltration in Anserine Bursitis Treatment
Lead sponsor
Universidad Autonoma de Nuevo Leon
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2009
Completion date
July 31, 2010
Enrollment
58 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bursitis